Evidence map›Paper›PMID 42853602›Full record

ArticleeLife2026

Punctuated mutagenesis promotes multi-step evolutionary adaptation in human cancers.

Christopher J Graser, Wenbo Wu, Cole Christini, Mia Peljak, Franziska Michor

Abstract read
PubMed Publisher
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Christopher J GraserDepartment of Data Science, Dana-Farber Cancer Institute, Boston, United States.ORCID https://orcid.org/0009-0003-8552-7767
Wenbo WuDepartment of Data Science, Dana-Farber Cancer Institute, Boston, United States.
Cole ChristiniDepartment of Data Science, Dana-Farber Cancer Institute, Boston, United States.
Mia PeljakDepartment of Pathology, New York University School of Medicine, New York, United States.
Franziska MichorDepartment of Data Science, Dana-Farber Cancer Institute, Boston, United States.ORCID https://orcid.org/0000-0003-4869-8842

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rate of acquisition of genomic changes in cancer has been the topic of much discussion, with several recent investigations finding evidence of punctuated evolution instead of gradual accumulation of such changes. Despite forays into the description and quantification of these punctuated events, the effects of such changes on subsequent cancer evolution remain incompletely understood. Here we investigate how non-gradual mutagenesis affects the ability of tumor cells to acquire and retain fitness-enhancing adaptations. We find that punctuated mutagenesis significantly facilitates adaptation in scenarios where adaptation requires crossing a fitness valley, that is when multiple mutations are required which individually are maladaptive but jointly confer a fitness advantage. By increasing the probability that multiple mutations occur in close succession, punctuation increases the chance that mutants in a fitness valley mutate further to reach a fitness peak before going extinct. Analyzing data from The Cancer Genome Atlas, we find that tumors with signatures of APOBEC mutagenesis, which has been shown to proceed in episodic bursts, exhibit patterns consistent with higher rates of crossing fitness valleys. Lastly, we characterize how the interplay between this enhanced ability to cross fitness valleys and adaptation-limiting effects of clonal interference affects overall adaptability in complex fitness landscapes.

Indexed as

Adaptation, BiologicalAdaptation, PhysiologicalEvolution, MolecularMutagenesisNeoplasmsGenetic FitnessHumansMutationadaptationAPOBECcancercancer biologyevolutionary biologyhumanpunctuated evolutionpunctuated mutagenesisvalley crossing

Identifiers

PMID42853602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.